FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eli Gilboa

Research Profile

Living Beings

Physiology

Anatomy

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Alexey Berezhnoy; Paloma H Giangrande; C Andrew Stewart; William Thiel; Giorgio Trinchieri; James O Mcnamara; Eli Gilboa
Isolation and optimization of murine IL-10 receptor blocking oligonucleotide aptamers using high-throughput sequencing.
Eli Gilboa
mRNA leapfrogs DNA to show promise for therapeutic gene transfer.
Thomas Blankenstein; Pierre G Coulie; Eli Gilboa; Elizabeth M Jaffee
The determinants of tumour immunogenicity.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eli Gilboa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Alexey Berezhnoy; Paloma H Giangrande; C Andrew Stewart; William Thiel; Giorgio Trinchieri; James O Mcnamara; Eli Gilboa
Isolation and optimization of murine IL-10 receptor blocking oligonucleotide aptamers using high-throughput sequencing.
Molecular therapy : the journal of the American Society of Gene Therapy 2012;20(6):1242-50.
2012: Eli Gilboa
mRNA leapfrogs DNA to show promise for therapeutic gene transfer.
Molecular therapy : the journal of the American Society of Gene Therapy 2012;20(4):694-5.
2012: Thomas Blankenstein; Pierre G Coulie; Eli Gilboa; Elizabeth M Jaffee
The determinants of tumour immunogenicity.
Nature reviews. Cancer 2012;12(4):307-13.
2012: Alexey Berezhnoy; Randall Brenneman; Marcio Bajgelman; Dawn Seales; Eli Gilboa
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition.
Molecular therapy. Nucleic acids 2012;1():e51.
2011: Fernando Pastor; James O McNamara; Despina Kolonias; Eli Gilboa
Targeting 4-1BB costimulation to disseminated tumor lesions with bi-specific oligonucleotide aptamers.
Molecular therapy : the journal of the American Society of Gene Therapy 2011;19(10):1878-86.
2010: Fernando Pastor; Despina Kolonias; Paloma H Giangrande; Eli Gilboa
Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay.
Nature 2010;465(7295):227-30.
2010: T van Es; Gijs van Puijvelde; A C Foks; K L L Habets; Ilze Bot; Eli Gilboa; Theo Van berkel; Johan Kuiper
Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis.
Atherosclerosis 2010;209(1):74-80.
2009: Jing Zhou; Boonchoy Soontornworajit; Jacob Martin; Bruce A Sullenger; Eli Gilboa; Yong Wang
A hybrid DNA aptamer-dendrimer nanomaterial for targeted cell labeling.
Macromolecular bioscience 2009;9(9):831-5.
2008: Claudia Dollins; Smita Nair; David Boczkowski; Jaewoo Lee; Juliana M Layzer; Eli Gilboa; Bruce A Sullenger
Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer.
Chemistry & biology 2008;15(7):675-82.
2008: James O McNamara; Despina Kolonias; Fernando Pastor; Robert S Mittler; Lieping Chen; Paloma H Giangrande; Bruce A Sullenger; Eli Gilboa
Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice.
The Journal of clinical investigation 2008;118(1):376-86.
2007: Nada M Melhem; Xiang Dong Liu; David Boczkowski; Eli Gilboa; Simon M Barratt-Boyes
Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag.
European journal of immunology 2007;37(8):2164-73.
2007: Eli Gilboa
DC-based cancer vaccines.
The Journal of clinical investigation 2007;117(5):1195-203.
2007: Smita Nair; David Boczkowski; Martin Fassnacht; David Pisetsky; Eli Gilboa
Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity.
Cancer research 2007;67(1):371-80.
2006: James O McNamara; Eran R Andrechek; Yong Wang; Kristi D Viles; Rachel E Rempel; Eli Gilboa; Bruce A Sullenger; Paloma H Giangrande
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.
Nature biotechnology 2006;24(8):1005-15.
2006: Peter E Fecci; Alison E Sweeney; Peter M Grossi; Smita K Nair; Chris A Learn; Duane A Mitchell; Xiuyu Cui; Thomas J Cummings; Darell D Bigner; Eli Gilboa; John H Sampson
Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4294-305.
2006: Paul R Hess; David Boczkowski; Smita K Nair; David Snyder; Eli Gilboa
Vaccination with mRNAs encoding tumor-associated antigens and granulocyte-macrophage colony-stimulating factor efficiently primes CTL responses, but is insufficient to overcome tolerance to a model tumor/self antigen.
Cancer immunology, immunotherapy : CII 2006;55(6):672-83.
2006: Daniel G Kavanagh; Daniel E Kaufmann; Sherzana Sunderji; Nicole Frahm; Sylvie Le Gall; David Boczkowski; Eric S Rosenberg; David R Stone; Mary N Johnston; Bradford S Wagner; M Tauheed Zaman; Christian Brander; Eli Gilboa; Bruce D Walker; Nina Bhardwaj
Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef.
Blood 2006;107(5):1963-9.
2005: Jaewoo Lee; Martin Fassnacht; Smita Nair; David Boczkowski; Eli Gilboa
Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts.
Cancer research 2005;65(23):11156-63.
2005: Jens Dannull; Zhen Su; David A Rizzieri; Benjamin K Yang; Doris Coleman; Donna Yancey; Aijing Zhang; Philipp Dahm; Nelson Chao; Eli Gilboa; Zhen Su
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.
The Journal of clinical investigation 2005;115(12):3623-33.
2005: Martin Fassnacht; Jaewoo Lee; Caterina Milazzo; David Boczkowski; Zhen Su; Smita Nair; Eli Gilboa
Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(15):5566-71.
2005: Jens Dannull; Smita Nair; Zhen Su; David Boczkowski; Christian DeBeck; Benjamin Yang; Eli Gilboa; Zhen Su
Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand.
Blood 2005;105(8):3206-13.
2005: Zhen Su; Jens Dannull; Benjamin K Yang; Philipp Dahm; Doris Coleman; Donna Yancey; Sylvia Sichi; Donna Niedzwiecki; David Boczkowski; Eli Gilboa; Zhen Su
Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(6):3798-807.
2004: Eli Gilboa
Knocking the SOCS1 off dendritic cells.
Nature biotechnology 2004;22(12):1521-2.
2004: Eli Gilboa; Zhen Su
Cancer immunotherapy with mRNA-transfected dendritic cells.
Immunological reviews 2004;199():251-63.
2004: Robin M Cisco; Zeinab Abdel-Wahab; Jens Dannull; Smita Nair; Douglas S Tyler; Eli Gilboa; Zhen Su; Yehia A Daaka; Scott K Pruitt
Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive toll-like receptor 4.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(11):7162-8.
2004: Eli Gilboa
The promise of cancer vaccines.
Nature reviews. Cancer 2004;4(5):401-11.
2004: Xinsheng Liao; Yongqing Li; Chiara Bonini; Smita Nair; Eli Gilboa; Philip D Greenberg; Cassian Yee
Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes.
Molecular therapy : the journal of the American Society of Gene Therapy 2004;9(5):757-64.
2003: Smita Nair; Catherine McLaughlin; Alon Z Weizer; Zhen Su; David Boczkowski; Jens Dannull; Zhen Su; Eli Gilboa
Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(11):6275-82.
2003: Yangbing Zhao; David Boczkowski; Smita K Nair; Eli Gilboa
Inhibition of invariant chain expression in dendritic cells presenting endogenous antigens stimulates CD4+ T-cell responses and tumor immunity.
Blood 2003;102(12):4137-42.
2003: Sandra Santulli-Marotto; Smita K Nair; Christopher P Rusconi; Bruce A Sullenger; Eli Gilboa
Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity.
Cancer research 2003;63(21):7483-9.
2003: Smita Nair; David Boczkowski; Benjamin J Moeller; Mark Dewhirst; Zhen Su; Eli Gilboa
Synergy between tumor immunotherapy and antiangiogenic therapy.
Blood 2003;102(3):964-71.
2003: Michael A Morse; Smita K Nair; Paul J Mosca; Amy C Hobeika; Timothy M Clay; Yuping Deng; David Boczkowski; Alan D Proia; Donna Neidzwiecki; Pierre-Alain Clavien; Herbert I Hurwitz; Jeffrey Schlom; Eli Gilboa; H Kim Lyerly
Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA.
Cancer investigation 2003;21(3):341-9.
2003: Zhen Su; Jens Dannull; Axel Heiser; Donna Yancey; Scott K Pruitt; John Madden; Doris Coleman; Donna Niedzwiecki; Eli Gilboa; Zhen Su
Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells.
Cancer research 2003;63(9):2127-33.
2002: Zhen Su; Zhen Su; Alon Z Weizer; Philipp Dahm; Donna Yancey; Vandana Turaga; John Higgins; David Boczkowski; Eli Gilboa; Jens Dannull
Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product.
Cancer research 2002;62(17):5041-8.
2002: Bruce A Sullenger; Eli Gilboa
Emerging clinical applications of RNA.
Nature 2002;418(6894):252-8.
2002: Smita K Nair; Michael Morse; David Boczkowski; R Ian Cumming; Ljiljana Vasovic; Eli Gilboa; H Kim Lyerly
Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells.
Annals of surgery 2002;235(4):540-9.
2002: Axel Heiser; Doris Coleman; Jens Dannull; Donna Yancey; Margaret A Maurice; Costas D Lallas; Philipp Dahm; Donna Niedzwiecki; Eli Gilboa; Zhen Su
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors.
The Journal of clinical investigation 2002;109(3):409-17.
2002: Michael A Morse; Smita K Nair; David Boczkowski; Douglas Tyler; Herbert I Hurwitz; Alan D Proia; Timothy M Clay; Jeffrey Schlom; Eli Gilboa; H Kim Lyerly
The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer.
International journal of gastrointestinal cancer 2002;32(1):1-6.
2002: Brenda Faiola; Carolyn Doyle; Eli Gilboa; Smita Nair
Influence of CD4 T cells and the source of major histocompatibility complex class II-restricted peptides on cytotoxic T-cell priming by dendritic cells.
Immunology 2002;105(1):47-55.
2001: Eli Gilboa
The risk of autoimmunity associated with tumor immunotherapy.
Nature immunology 2001;2(9):789-92.
2001: Kenneth L Phillips; Russell E Ware; S Hall; L Wilson; Tracy Gentry; Thad A Howard; Y Murakami; Makio Shibano; Takashi Machii; Eli Gilboa; Yuzuru Kanakura; J Takeda; Taroh Kinoshita; Wendell F Rosse; Clay A Smith
Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype.
Blood 2001;97(10):3004-10.
2001: Axel Heiser; Margaret A Maurice; Donna Yancey; Ning Z Wu; Philipp Dahm; Scott K Pruitt; David Boczkowski; Smita K Nair; M S Ballo; Eli Gilboa; Zhen Su
Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(5):2953-60.
2000: Smita K Nair; Axel Heiser; David Boczkowski; A Majumdar; M Naoe; J S Lebkowski; Zhen Su; Eli Gilboa
Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
Nature medicine 2000;6(9):1011-7.
2000: Yuzo Kodaira; S K Nair; Lucile E Wrenshall; Eli Gilboa; Jeffrey L Platt
Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(3):1599-604.
2000: Courtney Thornburg; David Boczkowski; Eli Gilboa; Smita K Nair
Induction of cytotoxic T lymphocytes with dendritic cells transfected with human papillomavirus E6 and E7 RNA: implications for cervical cancer immunotherapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(4):412-8.
2000: William Larchian; Y Horiguchi; S K Nair; William R Fair; Warren D W Heston; Eli Gilboa
Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2913-20.
2000: Axel Heiser; Philipp Dahm; Donna Yancey; Margaret A Maurice; David Boczkowski; Smita K Nair; Eli Gilboa; Zhen Su
Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(10):5508-14.
2000: David Boczkowski; Smita K Nair; J H Nam; H Kim Lyerly; Eli Gilboa
Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells.
Cancer research 2000;60(4):1028-34.
1999: Eli Gilboa
How tumors escape immune destruction and what we can do about it.
Cancer immunology, immunotherapy : CII 1999;48(7):382-5.
1999: Eli Gilboa
The makings of a tumor rejection antigen.
Immunity 1999;11(3):263-70.
1999: Smita K Nair; S Hull; Doris Coleman; Eli Gilboa; H Kim Lyerly; Michael A Morse
Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA.
International journal of cancer. Journal international du cancer 1999;82(1):121-4.
1999: Smita Nair; PA Wearsch; D A Mitchell; JJ Wassenberg; Eli Gilboa; Christopher V Nicchitta
Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(11):6426-32.
1998: Michael A Morse; H Kim Lyerly; Eli Gilboa; E Thomas; Smita K Nair
Optimization of the sequence of antigen loading and CD40-ligand-induced maturation of dendritic cells.
Cancer research 1998;58(14):2965-8.
1998: D A Mitchell; Smita K Nair; Eli Gilboa
Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells.
European journal of immunology 1998;28(6):1923-33.
1998: Seong-Wook Lee; Eli Gilboa
High level accumulation of an aberrantly spliced human DHFR RNA species.
Molecules and cells 1998;8(2):189-200.
1998: Eli Gilboa; Smita K Nair; H Kim Lyerly
Immunotherapy of cancer with dendritic-cell-based vaccines.
Cancer immunology, immunotherapy : CII 1998;46(2):82-7.
1998: Smita K Nair; David Boczkowski; Michael Morse; R Ian Cumming; H Kim Lyerly; Eli Gilboa
Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.
Nature biotechnology 1998;16(4):364-9.
1998: G B McCowage; Kenneth L Phillips; Tracy Gentry; S Hull; Joanne Kurtzberg; Eli Gilboa; Clay Smith
Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells.
Experimental hematology 1998;26(4):288-98.
1997: DM Ashley; Brenda Faiola; Smita Nair; Laura P Hale; Darell D Bigner; Eli Gilboa
Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors.
The Journal of experimental medicine 1997;186(7):1177-82.
1997: Smita K Nair; David Snyder; B T Rouse; Eli Gilboa
Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts.
International journal of cancer. Journal international du cancer 1997;70(6):706-15.
1997: Bryan M Clary; EC Coveney; Ramila Philip; D G Blazer; Michael Morse; Eli Gilboa; H Kim Lyerly
Inhibition of established pancreatic cancers following specific active immunotherapy with interleukin-2 gene-transduced tumor cells.
Cancer gene therapy 1997;4(2):97-104.
1997: Smita K Nair; David Boczkowski; David Snyder; Eli Gilboa
Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines.
European journal of immunology 1997;27(3):589-97.
1997: Angel Porgador; Herman F Staats; Brenda Faiola; Eli Gilboa; TJ Palker
Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(2):834-41.
1997: Bryan M Clary; EC Coveney; D G Blazer; Ramila Philip; Mohan Philip; Michael Morse; Eli Gilboa; H Kim Lyerly
Active immunization with tumor cells transduced by a novel AAV plasmid-based gene delivery system.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(1):26-37.
1996: Clay Smith; S W Lee; E Wong; Humilidad F Gallardo; K Page; O Gaspar; J Lebkowski; Eli Gilboa
Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys.
Antiviral research 1996;32(2):99-115.
1996: K Phillips; T Gentry; G McCowage; Eli Gilboa; Clay Smith
Cell-surface markers for assessing gene transfer into human hematopoietic cells.
Nature medicine 1996;2(10):1154-6.
1996: T Rudoll; K Phillips; S W Lee; S Hull; O Gaspar; N Sucgang; Eli Gilboa; Clay Smith
High-efficiency retroviral vector mediated gene transfer into human peripheral blood CD4+ T lymphocytes.
Gene therapy 1996;3(8):695-705.
1996: David Boczkowski; Smita K Nair; D Snyder; Eli Gilboa
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
The Journal of experimental medicine 1996;184(2):465-72.
1996: Angel Porgador; D Snyder; Eli Gilboa
Induction of antitumor immunity using bone marrow-generated dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(8):2918-26.
1996: Smita K Nair; D Snyder; Eli Gilboa
Cells treated with TAP-2 antisense oligonucleotides are potent antigen-presenting cells in vitro and in vivo.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(5):1772-80.
1996: Eli Gilboa
Immunotherapy of cancer with genetically modified tumor vaccines.
Seminars in oncology 1996;23(1):101-7.
1995: S W Lee; Humilidad F Gallardo; O Gaspar; Clay Smith; Eli Gilboa
Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
Gene therapy 1995;2(6):377-84.
1995: Angel Porgador; Eli Gilboa
Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.
The Journal of experimental medicine 1995;182(1):255-60.
1995: Zhen Su; David Boczkowski; KM Roberson; D W Edwards; Mohan Philip; Ramila Philip; T Rudoll; Clay Smith; C Robertson; Eli Gilboa
Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer.
Cancer research 1995;55(11):2366-72.
1995: Juri Gelovani Tjuvajev; B Gansbacher; R Desai; Bradley Beattie; Michael Gordon Kaplitt; Cornelia Matei; Jason A Koutcher; Eli Gilboa; Ronald Blasberg
RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.
Cancer research 1995;55(9):1902-10.
1995: Zhen Su; Eli Gilboa
Gene therapy approaches in urologic oncology.
Surgical oncology clinics of North America 1995;4(2):203-18.
1995: Zhen Su; Eli Gilboa
Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment.
Cancer investigation 1995;13(2):193-201.
1994: S W Lee; Humilidad F Gallardo; Eli Gilboa; Clay Smith
Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Journal of virology 1994;68(12):8254-64.
1994: Eli Gilboa; H K Lyerly; Zhen Su; S Saito
Immunotherapy of cancer using cytokine gene-modified tumor vaccines.
Seminars in cancer biology 1994;5(6):409-17.
1994: S Saito; R Bannerji; B Gansbacher; Felicia M Rosenthal; P Romanenko; Warren D W Heston; W R Fair; Eli Gilboa
Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines.
Cancer research 1994;54(13):3516-20.
1994: Zhen Su; Warren D W Heston; Eli Gilboa; W R Fair
An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer.
The Prostate 1994;24(6):291-8.
1994: M X Li; Debabrata Banerjee; SC Zhao; B I Schweitzer; Shin Mineishi; Eli Gilboa; Joseph R Bertino
Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction.
Blood 1994;83(11):3403-8.
1994: Zhen Su; Felicia M Rosenthal; R Bannerji; Warren D W Heston; W R Fair; B Gansbacher; Eli Gilboa
Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.
Cancer research 1994;54(7):1760-5.
1994: Eli Gilboa; Clay Smith
Gene therapy for infectious diseases: the AIDS model.
Trends in genetics : TIG 1994;10(4):139-44.
1994: R Bannerji; C D Arroyo; C Cordon-Cardo; Eli Gilboa
The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(5):2324-32.
1994: SC Zhao; M X Li; Debabrata Banerjee; B I Schweitzer; Shin Mineishi; Eli Gilboa; Joseph R Bertino
Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase.
Cancer gene therapy 1994;1(1):27-33.
1993: L L Chen; B Gansbacher; Eli Gilboa; R Taetle; J Oval; M S Hibbs; C K Huang; M L Clawson; SF Bilgrami; Joseph Schlessinger
Retroviral gene transfer of epidermal growth factor receptor into HL60 cells results in a partial block of retinoic acid-induced granulocytic differentiation.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(9):769-76.
1993: Claudio Bordignon; F Mavilio; G Ferrari; P Servida; Alberto G Ugazio; Luigi D Notarangelo; Eli Gilboa; silvano rossini; Richard J O'Reilly; C A Smith
Transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID.
Human gene therapy 1993;4(4):513-20.
1993: J Connor; R Bannerji; S Saito; Warren D W Heston; W Fair; Eli Gilboa
Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.
The Journal of experimental medicine 1993;177(4):1127-34.
1993: Angel Porgador; R Bannerji; Y Watanabe; M Feldman; Eli Gilboa; Lea Eisenbach
Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(4):1458-70.
1993: Angel Porgador; B Gansbacher; R Bannerji; Esther Tzehoval; Eli Gilboa; M Feldman; Lea Eisenbach
Anti-metastatic vaccination of tumor-bearing mice with IL-2-gene-inserted tumor cells.
International journal of cancer. Journal international du cancer 1993;53(3):471-7.
1993: C Smith; Marcus O Muench; M Knizewski; Eli Gilboa; Malcolm A S Moore
Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in-vivo model of acute non-lymphocytic leukemia.
Leukemia 1993;7(2):310-7.
1992: B Gansbacher; K Zier; K Cronin; P A Hantzopoulos; B Bouchard; Alan N Houghton; Eli Gilboa; David W Golde
Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells.
Blood 1992;80(11):2817-25.
1992: G Gastl; CL Finstad; Anna Guarini; George J Bosl; Eli Gilboa; Neil H Bander; B Gansbacher
Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.
Cancer research 1992;52(22):6229-36.
1992: M Li; P A Hantzopoulos; Debabrata Banerjee; SC Zhao; B I Schweitzer; Eli Gilboa; Joseph R Bertino
Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors.
Human gene therapy 1992;3(4):381-90.
1992: M Suchi; Tama Dinur; Robert J Desnick; Shimon Gatt; Lygia Pereira; Eli Gilboa; Edward H Schuchman
Retroviral-mediated transfer of the human acid sphingomyelinase cDNA: correction of the metabolic defect in cultured Niemann-Pick disease cells.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(8):3227-31.
1992: T C Lee; B A Sullenger; Humilidad F Gallardo; G E Ungers; Eli Gilboa
Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells.
The New biologist 1992;4(1):66-74.
1991: B A Sullenger; Humilidad F Gallardo; G E Ungers; Eli Gilboa
Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation.
Journal of virology 1991;65(12):6811-6.
1991: J V Fetten; N Roy; Eli Gilboa
A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes.
Journal of immunology (Baltimore, Md. : 1950) 1991;147(8):2697-705.
1991: G Ferrari; silvano rossini; R Giavazzi; D Maggioni; N Nobili; M Soldati; G Ungers; F Mavilio; Eli Gilboa; Claudio Bordignon
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency.
Science (New York, N.Y.) 1991;251(4999):1363-6.
1991: J Oval; R Hershberg; B Gansbacher; Eli Gilboa; Joseph Schlessinger; R Taetle
Expression of functional epidermal growth factor receptors in a human hematopoietic cell line.
Cancer research 1991;51(1):150-6.
1990: B Gansbacher; R Bannerji; B Daniels; K Zier; K Cronin; Eli Gilboa
Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity.
Cancer research 1990;50(24):7820-5.
1990: B A Sullenger; T C Lee; C A Smith; G E Ungers; Eli Gilboa
Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication.
Molecular and cellular biology 1990;10(12):6512-23.
1990: B A Sullenger; Humilidad F Gallardo; G E Ungers; Eli Gilboa
Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication.
Cell 1990;63(3):601-8.
1990: B Gansbacher; K Zier; B Daniels; K Cronin; R Bannerji; Eli Gilboa
Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.
The Journal of experimental medicine 1990;172(4):1217-24.
1990: John H Wolfe; E H Schuchman; L E Stramm; E A Concaugh; M E Haskins; Gustavo D Aguirre; Donald F Patterson; R J Desnick; Eli Gilboa
Restoration of normal lysosomal function in mucopolysaccharidosis type VII cells by retroviral vector-mediated gene transfer.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(8):2877-81.
1990: Eli Gilboa
Retroviral gene transfer: applications to human therapy.
Progress in clinical and biological research 1990;352():301-11.
1989: Claudio Bordignon; S F Yu; C A Smith; P Hantzopoulos; G E Ungers; C A Keever; Richard J O'Reilly; Eli Gilboa
Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(17):6748-52.
1989: P A Hantzopoulos; B A Sullenger; G Ungers; Eli Gilboa
Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(10):3519-23.
1989: Philip W Kantoff; A W Flake; M A Eglitis; S Scharf; S Bond; Eli Gilboa; Henry A Erlich; M R Harrison; Esmail D Zanjani; W French Anderson
In utero gene transfer and expression: a sheep transplantation model.
Blood 1989;73(4):1066-73.
1989: T von Rüden; Eli Gilboa
Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA.
Journal of virology 1989;63(2):677-82.
1988: L H Hwang; Eli Gilboa
Intron sequences may influence the efficiency and correctness in selecting a 3'-splicing acceptor site.
Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association 1988;87(12):1141-8.
1988: Eli Gilboa
Retroviral gene transfer: applications to human therapy.
Advances in experimental medicine and biology 1988;241():29-33.
1987: J A Rasmussen; Eli Gilboa
Significance of DNase I-hypersensitive sites in the long terminal repeats of a Moloney murine leukemia virus vector.
Journal of virology 1987;61(5):1368-74.
1987: D Armentano; S F Yu; Philip W Kantoff; T von Ruden; W F Anderson; Eli Gilboa
Effect of internal viral sequences on the utility of retroviral vectors.
Journal of virology 1987;61(5):1647-50.
1986: Eli Gilboa
Retrovirus vectors and their uses in molecular biology.
BioEssays : news and reviews in molecular, cellular and developmental biology 1986;5(6):252-7.
1986: S F Yu; T von Rüden; Philip W Kantoff; C Garber; M Seiberg; U Rüther; W F Anderson; E F Wagner; Eli Gilboa
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(10):3194-8.
1986: L Wolff; J F Mushinski; Eli Gilboa; Herbert C Morse
Induction of hematopoietic tumors using a viral construct containing c-myc cDNA from normal mouse spleen.
Current topics in microbiology and immunology 1986;132():33-9.
1986: W French Anderson; Philip W Kantoff; M A Eglitis; Eli Gilboa
Gene transfer into animals by retroviral vectors.
Basic life sciences 1986;37():59-65.
1985: M A Eglitis; Philip W Kantoff; Eli Gilboa; W French Anderson
Gene expression in mice after high efficiency retroviral-mediated gene transfer.
Science (New York, N.Y.) 1985;230(4732):1395-8.
1985: G Keller; C Paige; Eli Gilboa; E F Wagner
Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors.
Nature 1985;318(6042):149-54.
1985: M Taketo; Eli Gilboa; M I Sherman
Isolation of embryonal carcinoma cell lines that express integrated recombinant genes flanked by the Moloney murine leukemia virus long terminal repeat.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(8):2422-6.
1985: E F Wagner; G Keller; Eli Gilboa; U Rüther; C Stewart
Gene transfer into murine stem cells and mice using retroviral vectors.
Cold Spring Harbor symposia on quantitative biology 1985;50():691-700.
1984: L S Hwang; J Park; Eli Gilboa
Role of intron-contained sequences in formation of moloney murine leukemia virus env mRNA.
Molecular and cellular biology 1984;4(11):2289-97.
1984: L H Hwang; Eli Gilboa
Expression of genes introduced into cells by retroviral infection is more efficient than that of genes introduced into cells by DNA transfection.
Journal of virology 1984;50(2):417-24.
1984: J J Champoux; Eli Gilboa; David Baltimore
Mechanism of RNA primer removal by the RNase H activity of avian myeloblastosis virus reverse transcriptase.
Journal of virology 1984;49(3):686-91.
1982: Eli Gilboa; M Kolbe; K Noonan; R Kucherlapati
Construction of a mammalian transducing vector from the genome of Moloney murine leukemia virus.
Journal of virology 1982;44(3):845-51.
1981: S P Goff; O N Witte; Eli Gilboa; N Rosenberg; David Baltimore
Genome structure of Abelson murine leukemia virus variants: proviruses in fibroblasts and lymphoid cells.
Journal of virology 1981;38(2):460-8.
1981: C Shoemaker; S Goff; Eli Gilboa; M Paskind; S W Mitra; David Baltimore
Structure of cloned retroviral circular DNAs: implications for virus integration.
Cold Spring Harbor symposia on quantitative biology 1981;45 Pt 2():711-7.
1980: S P Goff; Eli Gilboa; O N Witte; David Baltimore
Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA.
Cell 1980;22(3):777-85.
1980: C Shoemaker; S Goff; Eli Gilboa; M Paskind; S W Mitra; David Baltimore
Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(7):3932-6.
1979: Eli Gilboa; S W Mitra; S Goff; David Baltimore
A detailed model of reverse transcription and tests of crucial aspects.
Cell 1979;18(1):93-100.
1979: S W Mitra; S Goff; Eli Gilboa; David Baltimore
Synthesis of a 600-nucleotide-long plus-strand DNA by virions of Moloney murine leukemia virus.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(9):4355-9.
1979: Eli Gilboa; S Goff; Anthony F Shields; Fayth K Yoshimura; S Mitra; David Baltimore
In vitro synthesis of a 9 kbp terminally redundant DNA carrying the infectivity of Moloney murine leukemia virus.
Cell 1979;16(4):863-74.
1979: David Baltimore; Eli Gilboa; E Rothenberg; Fayth K Yoshimura
Production of a discrete, infectious, double-stranded DNA by reverse transcription in virions of Moloney murine leukemia virus.
Cold Spring Harbor symposia on quantitative biology 1979;43 Pt 2():869-74.
1978: Y Groner; Eli Gilboa; H Aviv
Methylation and capping of RNA polymerase II primary transcripts by HeLa nuclear homogenates.
Biochemistry 1978;17(6):977-82.
1977: Eli Gilboa; H Soreq; H Aviv
Initiation of RNA synthesis in isolated nuclei.
European journal of biochemistry / FEBS 1977;77(2):393-400.
1977: C Prives; Eli Gilboa; M Revel; E Winocour
Cell-free translation of simian virus 40 early messenger RNA coding for viral T-antigen.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(2):457-61.
1976: Eli Gilboa; H Aviv
Preferential synthesis of viral late RNA by nuclei isolated from SV40 lytically infected cells.
Cell 1976;7(4):567-73.
1975: C Prives; Eli Gilboa; H Aviv; M Revel; E Winocour
Proceedings: Purification and translation of mRNA coding for SV40 proteins.
Israel journal of medical sciences 1975;11(11):1206.
1975: Eli Gilboa; C L Prives; H Aviv
Purification of SV-40 messenger RNA by hybridization to SV-40 DNA covalently bound to Sepharose.
Biochemistry 1975;14(19):4215-20.
1975: C L Prives; H Aviv; Eli Gilboa; M Revel; E Winocour
The cell-free translation of SV40 messenger RNA.
Cold Spring Harbor symposia on quantitative biology 1975;39 Pt 1():309-16.
1973: Eli Gilboa; Y Elkana; M Rigbi
Purification and properties of human acrosin.
European journal of biochemistry / FEBS 1973;39(1):85-92.